Gainers
- Enveric Biosciences, Inc. ENVB climbed 85.3% to $5.43 in reaction to acquiring an exclusive, perpetual license for novel molecules from Diverse Biotech. It is a biopharmaceutical company focused on developing new molecules for oncology.
- Koss Corporation KOSS shares climbed 59.2% to $28.50.
- MediciNova, Inc. MNOV shares jumped 42.3% to $8.08 after the biopharmaceutical company announced a partnership with the Biomedical Advanced Research and Development Authority (BARDA) to repurpose MN-166 (ibudilast) as a potential medical countermeasure against lung damage induced by chlorine gas.
- Express, Inc. EXPR gained 29.8% to $4.39 after the company reported better-than-expected fourth-quarter results.
- Talend S.A. TLND surged 28% to $65.68 after Private equity investment firm Thoma Bravo inked a memorandum of understanding (MoU) with data integration and data integrity provider Talend to acquire it for $2.4 billion or $66 per share, signifying a 29% premium to Talend’s closing price of $51.30 on March 9.
- Evofem Biosciences, Inc. EVFM rose 24.4% to $2.8238. Evofem Biosciences, last week, reported worse-than-expected Q4 EPS.
- Viant Technology Inc. DSP gained 18.4% to $46.85. Viant Technology, last month, priced its IPO at $25 per share.
- Inari Medical, Inc. NARI climbed 18.1% to $117.33 after the company reported better-than-expected Q4 results and issued strong revenue guidance.
- United Natural Foods, Inc. UNFI surged 17.8% to $35.94 after the company reported better-than-expected Q4 earnings.
- Biodesix, Inc. BDSX climbed 16.1% to $21.56.
- SIFCO Industries, Inc. SIF gained 15.8% to $10.36.
- REV Group, Inc. REVG climbed 15.1% to $16.26 after the company reported better-than-expected Q4 results.
- ACADIA Pharmaceuticals Inc. ACAD surged 15% to $28.80. ACADIA Pharmaceuticals recently received a notification from the FDA indicating 'the FDA has identified deficiencies that preclude discussion of labeling and post-marketing requirements/commitments at this time.'
- Earthstone Energy, Inc. ESTE jumped 15% to $8.26.
- Affimed N.V. AFMD gained 14.4% to $6.26 after the company announced the continuation of its REDIRECT study of AFM13 in PTCL.
- Build-A-Bear Workshop, Inc. BBW jumped 14.4% to $8.17 after the company reported better-than-expected Q4 results.
- Sino-Global Shipping America, Ltd. SINO shares gained 14.3% to $6.32.
- Datasea Inc. DTSS gained 13.7% to $3.72.
- Barnes & Noble Education, Inc. BNED surged 13.5% to $8.10 after Needham maintained its Buy rating and raised its price target from $5 to $9 per share.
- Atossa Therapeutics, Inc. ATOS shares rose 11.3% to $2.76 after gaining over 16% on Tuesday. Atossa Therapeutics, last month, announced final results from its Phase 1 study evaluating AT-301 administered by nasal spray. AT-301 is being developed for at-home use for patients recently diagnosed with COVID-19..
- LAIX Inc. LAIX rose 8.9% to $2.95 after gaining around 16% on Tuesday.
- Obalon Therapeutics, Inc. OBLN gained 8% to $3.82 after climbing 18% on Tuesday.
- CN Energy Group. Inc. CNEY shares rose 7.4% to $4.82. The company, last month, priced its IPO at $4 per share.
- Lion Group Holding Ltd. LGHL rose 7.2% to $3.0750 after surging around 12% on Tuesday.
Find out what's going on in today's market and bring any questions you have to Benzinga's PreMarket Prep.
Check out these big penny stock gainers and losers
Losers
- Just Energy Group Inc. JE shares dipped 38.5% to $2.43 as the company said it received creditor protection under Chapter 15 of the Bankruptcy Code in the United States.
- INVO Bioscience, Inc. INVO fell 37.6% to $5.87. The company’s stock jumped 202% on Tuesday after the company said it has amended its exclusive U.S. commercialization agreement with Ferring Pharmaceuticals.
- Second Sight Medical Products, Inc. EYES fell 30.6% to $10.74 after jumping over 31% on Tuesday. The company, on Friday, reported FDA approval for its Argus 2s Rentinal Prosthesis Systems.
- Sundance Energy Inc. SNDE fell 26.4% to $1.73 after the company announced that it would file for Chapter 11 Bankruptcy.
- MingZhu Logistics Holdings Limited YGMZ dropped 25.8% to $5.48 after the company announced a $20 million registered direct offering.
- Sintx Technologies, Inc. SINT fell 23.7% to $2.1903 after jumping 58% on Tuesday.
- AnPac Bio-Medical Science Co., Ltd.ANPC fell 23.1% to $6.62. AnPac Bio-Medical Science shares jumped over 49% on Tuesday as the company said it has developed and completed evaluations for its CDA Pro Cancer Detection Sensor.
- Tupperware Brands Corporation TUP dropped 19% to $26.23after the company reported worse-than-expected Q4 results.
- Espey Mfg. & Electronics Corp. ESP dipped 17.6% to $15.20 after the company announced it suspended its quarterly dividend.
- MultiPlan Corporation MPLN dropped 17.6% to $6.41 after the company reported downbeat Q4 earnings.
- Auris Medical Holding Ltd. EARS shares declined 17.3% to $4.30.
- Anchiano Therapeutics Ltd. ANCN dropped 17.2% to $4.19.
- Oragenics, Inc. OGEN fell 16.4% to $1.0450. Oragenics shares jumped around 48% on Tuesday after announcing a deal related to its Terra CoV-2 vaccine candidate against COVID-19.
- TD Holdings, Inc. GLG dropped 13.4% to $1.9750.
- Brickell Biotech, Inc. BBI fell 12.7% to $1.0650 after the company reported worse-than-expected Q4 earnings.
- Quidel Corporation QDEL fell 12.7% to $136.00.
- Vertex, Inc. VERX dropped 12.6% to $27.32. Vertex posted upbeat Q4 results, but issued weak Q1 sales forecast.
- New Oriental Education & Technology Group Inc. EDU dropped 12.1% to $163.38.
- OpGen, Inc. OPGN fell 11.8% to $2.69 after gaining 14% on Tuesday. OpGen, on Monday, announced the publication of final study results of the Unyvero HPN Panel for diagnostics of bacterial co-infections in ICU patients with COVID-19 pneumonia.
- Exela Technologies, Inc. XELA fell 7.8% to $4.25. Exela Technologies shares jumped 179% on Tuesday after the company said it won a 10-year, $90-million contract delivering data transformation solutions for a major US insurer.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Loading...
Posted In:
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in